Can Heliox improve the sensation of breathlessness and increase exercise duration in chronic obstructive pulmonary disease; A prospective randomized trial.

Department of Respiratory Medicine, Repatriation General Hospital0 个研究点目标入组 15 人开始时间: 2008年9月30日最近更新: 2020年1月13日

试验速览

暂无简介。

•Are aged over 40
•Chronic Obstructive Pulmonary Disease (COPD) of at least Stage III as per the Global initiative for chronic Obstructive Lung Disease (GOLD) guidelines, Forced Expiratory Volume in the first second (FEV1) <= 50% predicted post bronchodilator.
•Are able to give informed written consent prior to entering the study.
•Can comply with scheduled visit and all study related activities

•Any clearly documented history of adult asthma or chronic respiratory disorders (e.g. primary bronchiectasis, pulmonary fibrosis or any clearly documented history of adult asthma or chronic respiratory disorders (e.g. primary bronchiectasis, pulmonary fibrosis, pneumoconiosis) other than COPD.
•Any contraindication for Cardio Pulmonary Exercise Testing (CPET), as per American Thoracic Society and American College of Chest Physicians guidelines (ATS/ACCP 2003)
•Participating in a research study or use of any investigational drug during this studys, pneumoconiosis) other than COPD.

发起方

Department of Respiratory Medicine, Repatriation General Hospital